Switch to:
More From Other Websites
AbbVie Q2 Earnings Top on Humira Sales, Shire In Focus Jul 25 2014
UCB's Brivaracetam Positive in Phase III Epilepsy Study Jul 24 2014
What Makes Biogen Idec a Biotech Standout? Jul 24 2014
Video: Celgene, Alexion Earnings Top, But Stocks Fall Jul 24 2014
Gilead Sciences: Now Can We Call It a Value Stock? Jul 24 2014
The Zacks Analyst Blog Highlights: AbbVie, Shire, Amgen, InterMune and Biogen Jul 24 2014
Biogen Idec (BIIB) Soars: Stock Adds 11.2% in Session Jul 24 2014
Biogen price target raised to $387 from $343 at Citigroup Jul 24 2014
Aced the SAT? Try this Cramer question Jul 23 2014
Biogen, Gilead Earnings Crush Q2 Estimates Jul 23 2014
Biogen results crush consensus Jul 23 2014
US STOCKS-Apple pushes S&P 500 to record close; Boeing hits Dow Jul 23 2014
S&P 500 Posts New High; Biotechs, Airlines, Builders Up Jul 23 2014
IPO Stock Watch: Biotechs Are Half Of July Calendar Jul 23 2014
Biogen's Results Cure Some Pain Jul 23 2014
Biogen Idec Beats And Raises: Reassessing Its Prospects Jul 23 2014
S&P 500 Flirts With High; Breadth Missing On Nasdaq Jul 23 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide